LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 3 | E22 | 72 | hr | 1235 | 3093 | 4156 | 0.7442 | 0.6360 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 1235 | 4423 | 4156 | 1.0642 | 1.0914 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 1235 | 4239 | 4156 | 1.0199 | 1.0284 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 1235 | 4395 | 4156 | 1.0575 | 1.0818 |
MCF7 | Erlotinib | 0.37 | uM | LJP5 | 1 | M22 | 72 | hr | 1235 | 4247 | 4156 | 1.0219 | 1.0311 |
MCF7 | Erlotinib | 0.37 | uM | LJP5 | 2 | M22 | 72 | hr | 1235 | 4484 | 4156 | 1.0789 | 1.1122 |
MCF7 | Erlotinib | 0.37 | uM | LJP5 | 3 | M22 | 72 | hr | 1235 | 4295 | 4156 | 1.0334 | 1.0475 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 1 | H10 | 72 | hr | 1235 | 1428 | 4156 | 0.3436 | 0.0659 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 2 | H10 | 72 | hr | 1235 | 1665 | 4156 | 0.4006 | 0.1471 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 3 | H10 | 72 | hr | 1235 | 1477 | 4156 | 0.3554 | 0.0827 |
MCF7 | R406 | 0.37 | uM | LJP6 | 1 | C16 | 72 | hr | 1235 | 3581 | 4156 | 0.8616 | 0.8031 |
MCF7 | R406 | 0.37 | uM | LJP6 | 2 | C16 | 72 | hr | 1235 | 3741 | 4156 | 0.9001 | 0.8579 |
MCF7 | R406 | 0.37 | uM | LJP6 | 3 | C16 | 72 | hr | 1235 | 3523 | 4156 | 0.8477 | 0.7832 |
MCF7 | Pictilisib | 0.37 | uM | LJP6 | 1 | D22 | 72 | hr | 1235 | 1280 | 4156 | 0.3080 | 0.0153 |
MCF7 | Pictilisib | 0.37 | uM | LJP6 | 2 | D22 | 72 | hr | 1235 | 1149 | 4156 | 0.2765 | -0.0296 |
MCF7 | Pictilisib | 0.37 | uM | LJP6 | 3 | D22 | 72 | hr | 1235 | 1180 | 4156 | 0.2839 | -0.0190 |
MCF7 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1235 | 4997 | 4156 | 1.2023 | 1.2879 |
MCF7 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1235 | 3864 | 4156 | 0.9297 | 0.9000 |
MCF7 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1235 | 4732 | 4156 | 1.1385 | 1.1972 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 1 | O04 | 72 | hr | 1235 | 1301 | 4156 | 0.3130 | 0.0225 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 2 | O04 | 72 | hr | 1235 | 1399 | 4156 | 0.3366 | 0.0560 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 3 | O04 | 72 | hr | 1235 | 1486 | 4156 | 0.3575 | 0.0858 |
MCF7 | Geldanamycin | 0.37 | uM | LJP6 | 1 | O04 | 72 | hr | 1235 | 1344 | 4156 | 0.3234 | 0.0372 |
MCF7 | Geldanamycin | 0.37 | uM | LJP6 | 2 | O04 | 72 | hr | 1235 | 1233 | 4156 | 0.2967 | -0.0008 |
MCF7 | Geldanamycin | 0.37 | uM | LJP6 | 3 | O04 | 72 | hr | 1235 | 1386 | 4156 | 0.3335 | 0.0516 |